Acquisition Criteria Remain Conservative For Large Cardiovascular Firms
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific, Guidant and St. Jude Medical business development chiefs are reluctant to consider technologies outside their firms' core strengths when weighing potential acquisitions
You may also be interested in...
Split Rock Prepped To Invest In Medical Device Realm After Financing
Split Rock Partners expects to invest the majority of the $275 mil. it has raised from institutional investors into medical device start-up companies, according to Managing Director Dave Stassen
Split Rock Prepped To Invest In Medical Device Realm After Financing
Split Rock Partners expects to invest the majority of the $275 mil. it has raised from institutional investors into medical device start-up companies, according to Managing Director Dave Stassen
Can Cardio Firms Curb M&A? Selective Seeding Is Combo Product Strategy
Large cardiovascular device firms maintain they will exercise discipline in forming strategic alliances with biotech and IT companies, although such deals are considered key to sustainable growth